Journal of Clinical Endocrinology & Metabolism, Vol 71, 725-731, Copyright © 1990 by Endocrine Society

ARTICLES

Placental and pituitary growth hormone secretion during pregnancy in acromegalic women

A Beckers, A Stevenaert, JM Foidart, G Hennen and F Frankenne
Endocrinologie Experimentale et Clinique, Centre Hospitalier Universitaire, Liege, Belgium.

It is now well established that during the second half of normal pregnancy, the human placenta secretes its specific GH variant (placental GH) in increasing amounts up to delivery. During the same period, pituitary GH secretion is progressively suppressed. The present study was aimed at clarifying the physiology of GH secretion in pregnant acromegalic women. Two young women remained acromegalic despite transphenoidal removal of their pituitary adenoma. Increased basal levels of GH and insulin-like growth factor-I (IGF-I) as well as paradoxical GH release after TRH injection were noted. Both women became pregnant and delivered term babies without any complication. In both patients, pituitary GH remained elevated during the entire pregnancy, contrary to the situation in normal women. Paradoxical GH release after TRH treatment was also present, whereas no response was observed in five normal control subjects. GH pulsatility studies revealed a highly pulsatile secretory pattern of pituitary GH, in contrast to that in normal woman, whose placental GH is secreted tonically. Tissue placental GH concentrations were within the range of levels in normal placentas. An increase in serum IGF-I in late pregnancy was also similar to that observed in normal pregnancy. These findings confirm that increased IGF-I levels are not pituitary GH dependent in late pregnancy. They add new evidence that adenomatous somatotrophs lack an IGF-I-dependent feedback regulation present in normal somatotrophs.

This article has been cited by other articles:

				S. R. Brian, M. Bidlingmaier, M. P. Wajnrajch, S. A. Weinzimer, and S. E. Inzucchi Treatment of Acromegaly with Pegvisomant during Pregnancy: Maternal and Fetal Effects J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3374 - 3377. [Abstract] [Full Text] [PDF]

				R. Cozzi, R. Attanasio, and M. Barausse Pregnancy in acromegaly: a one-center experience. Eur. J. Endocrinol., August 1, 2006; 155(2): 279 - 284. [Abstract] [Full Text] [PDF]

				V. Herman-Bonert, M. Seliverstov, and S. Melmed Pregnancy in Acromegaly: Successful Therapeutic Outcome J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 727 - 731. [Full Text]

				P. Caron, L. Buscail, A. Beckers, J.-P. Esteve, A. Igout, G. Hennen, and C. Susini Expression of Somatostatin Receptor SST4 in Human Placenta and Absence of Octreotide Effect on Human Placental Growth Hormone Concentration during Pregnancy J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3771 - 3776. [Abstract] [Full Text] [PDF]